OREANDA-NEWS. February 26, 2010. Research and development of new products is one of the priorities of JSC "Grindeks" - every year "Grindeks" reviews different versions of new medications in cooperation with the leading Latvian and international research organizations.

Referring to a publication in the information portal BNS on 15 February 2010, "Grindeks" affirms the information about the discussions with the Latvian Institute of Organic Synthesis on development of the new molecule of Mildronate®. However, no decisions have been made.